26 Results

People

  1. Iasonos
    Iasonos
  2. Zhou
    Zhou
  3. Aghajanian
    Aghajanian
  4. O'Cearbhaill
    O'Cearbhaill
  5. Zamarin
    Zamarin
  6. Friedman
    Friedman
  7. Grisham
    Grisham
  8. Konner
    Konner
  9. Cadoo
    Cadoo
  10. Makker
    Makker

Groups

  1. Biostatistics Service (26)
  2. Department of Medicine (26)
  3. Epidemiology and Biostatistics (26)
  4. GDMT, Medicine (26)
  5. Gynecologic Medicine Service (26)
  6. Gynecology Disease Management Team (26)
  7. Human Oncology and Pathogenesis Program (26)
  8. Solid Tumor Oncology Division (26)
  9. Hematologic Malignancies, Division of (20)
  10. Body Imaging Service (11)
  1. "Qin Zhou"
  2. "Solid Tumor Oncology Division"
  3. "Dmitriy Zamarin"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (10)
Groups
  1. Biostatistics Service (26)
  2. Department of Medicine (26)
  3. Epidemiology and Biostatistics (26)
  4. GDMT, Medicine (26)
  5. Gynecologic Medicine Service (26)
  6. Gynecology Disease Management Team (26)

More Groups

People
  1. Alexia Iasonos (26)
  2. Dmitriy Zamarin (26)
  3. Qin Zhou (26)
  4. Carol Aghajanian (25)
  5. Roisin O'Cearbhaill (20)
  6. Claire Friedman (16)

More People

Years
  1. 2024 (1)
  2. 2023 (6)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (7)
  6. 2019 (4)

More Years

Publications
  1. Gynecologic Oncology (12)
  2. Journal of Clinical Oncology (7)
  3. Clinical Cancer Research (3)
  4. Journal for ImmunoTherapy of Cancer (2)
  5. International Journal of Gynecological Cancer (1)
  6. JCO Precision Oncology (1)
Publishers
  1. Elsevier Inc. (12)
  2. American Society of Clinical Oncology (8)
  3. American Association for Cancer Research (3)
  4. Biomed Central Ltd (2)
  5. Lippincott Williams & Wilkins (1)

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
    Journal Article

    Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival
    Meeting Abstract

    Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
    Journal Article

    Rios-Doria, E.; Momeni-Boroujeni, A.; Friedman, C. F.; Selenica, P.; Zhou, Q.; Wu, M.; Marra, A.; Leitao, M. M. Jr; Iasonos, A.; Alektiar, K. M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype
    Journal Article

    Dessources, K.; Ferrando, L.; Zhou, Q. C.; Iasonos, A.; Abu-Rustum, N. R.; Reis-Filho, J. S.; Riaz, N.; Zamarin, D.; Weigelt, B.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer
    Journal Article

    Ashley, C. W.; Selenica, P.; Patel, J.; Wu, M.; Nincevic, J.; Lakhman, Y.; Zhou, Q.; Shah, R. H.; Berger, M. F.; Da Cruz Paula, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save